• Phase 1/2 Trial to Test Yescarta-Utomilumab Combo in Refractory Large B-cell Lymphoma
  • FDA Promises Rapid Review of Kymriah for Diffuse Large B-cell Lymphoma
  • Cancer Doesn’t Have to Be Isolating
  • New Blood Stem Cell Harvest Method Could Speed Up Transplants
  • New CAR T-cell Production Method May Offer Faster, More Targeted Therapies, Study Reports
  • Age Alone Should Not Exclude Lymphoma Patients From Stem Cell Transplants, Researchers Argue
  • FDA Clears Voruciclib for Phase 1 Trial as Potential Treatment for Certain B-cell Malignancies
  • LLS Receives $5M to Support Research Programs in Mantle Cell Lymphoma
  • Breast Implants Associated with Small Increased Risk of Anaplastic Large-cell Lymphoma
  • FDA Cites Lack of Data About Blood Cancer Medications in Older People
  • Leukemia & Lymphoma Society Launches Navigating Cancer’s Network of Support
  • Cellectar Seeks FDA’s OK to Advance CLR 131 into Trials for Rare Pediatric Cancers